ALI posts big increase in third-quarter revenuesALI Technologies continues to gain momentum in the ultrasound miniPACS market, posting a 99% increase in revenues for its third quarter (end-June).For the period, ALI recorded revenues of (U.S.)
ALI Technologies continues to gain momentum in the ultrasound miniPACS market, posting a 99% increase in revenues for its third quarter (end-June).
For the period, ALI recorded revenues of (U.S.) $2.6 million, compared with $1.3 million for the same quarter in 1996. Net income was $398,000, compared with $20,000 in the third quarter of 1996. The Richmond, BC-based vendor also installed 12 more of its UltraPACS ultrasound digital image management systems in the third quarter, bringing its total installed base to 74 as of the end of June.
ALI credits rapid market growth in digital ultrasound image management, as well as increased customer awareness of ALI, for its strong financial results. The company has also benefited from increased opportunities to win lucrative orders to install UltraPACS in multihospital and regional network situations, such as the recent purchase by the Mayo Clinic (PNN 8/97), said Greg Peet, CEO.
While the company does not comment on the specific financial impact of its marketing partners, ALI believes that its OEM alliances are an important factor in its success.
"Specifically, the recent equity stake made by GE Medical Systems has been well received by ALI's existing and prospective clients, because ALI has been strengthened directly from a financial contribution and indirectly by stronger corporate sponsorship," Peet said.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.